908248-27-1

Basic information

• Product Name: 3-Pyridinol, 2-amino-5-nitro-
• Synonyms: 3-Pyridinol, 2-amino-5-nitro-;2-Amino-5-nitropyridin-3-ol;2-AMino-3-hydroxy-5-nitropyridine;2-amino-5-nitro-3-Pyridinol
• CAS NO: 908248-27-1
• Molecular Formula: C5H5N3O3
• Molecular Weight: 155.11
• Mol File: 908248-27-1.mol

Chemical Properties

• Boiling Point: 499.7°C at 760 mmHg
• Flash Point: 256°C
• Appearance: /
• Density: 1.629g/cm³
• Vapor Pressure: 1.31E-10mmHg at 25°C
• Refractive Index: 1.705
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 3-Pyridinol, 2-amino-5-nitro-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinol, 2-amino-5-nitro-(908248-27-1)
• EPA Substance Registry System: 3-Pyridinol, 2-amino-5-nitro-(908248-27-1)

Safety Data

• Hazardous Substances Data: 908248-27-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-Pyridinol, 2-amino-5-nitro-, is used as a building block for the synthesis of various drugs. Its unique chemical structure allows it to be a key component in the development of new pharmaceutical compounds, contributing to the advancement of medicine.
Used in Agrochemical Production:
3-Pyridinol, 2-amino-5-nitro-, serves as an intermediate in the production of agrochemicals. Its ability to modify biological molecules makes it a valuable asset in the creation of effective agricultural products, such as pesticides and herbicides, to improve crop yield and protect against pests.
Used in Research and Development:
3-Pyridinol, 2-amino-5-nitro-, is utilized in research and development for its potential applications in modifying biological molecules. Its unique properties make it a promising candidate for further exploration in various scientific fields, including medicine and agriculture, to discover new uses and applications.

InChI:InChI=1/C5H5N3O3/c6-5-4(9)1-3(2-7-5)8(10)11/h1-2,9H,(H2,6,7)

Upstream product

• 60832-72-6 2,3-dihydro[1,3]oxazolo[4,5-b]pyridin-2-one 
• 16867-03-1 2-amino-3-hydroxypyridine 
• 21594-54-7 6-nitro-2H,3H-[1,3]oxazolo[4,5-b]pyridin-2-one 
• 896161-12-9 2-amino-3-methoxy-5-nitropyridine 

Relevant articles and documents

FUSED IMIDAZOLE COMPOUNDS

The present invention provides compounds represented by formula (I), pharmaceutically acceptable salts thereof, N-oxides thereof, solvates thereof or prodrugs thereof (wherein the characters are as defined in the description). The compounds represented by formula (I) have affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 (GABAA α5) and act as GABAA α5 negative allosteric modulators (GABAA α5 NAM), so that they are useful in the prevention and/or treatment of diseases which are related to the GABAA α5 such as Alzheimer's disease.

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES

The present invention provides compounds of Formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite, such as Leishmaniasis, Human African Trypanosomiasis and Chagas disease.

CONDENSED HETEROCYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I) wherein R1, A, B, D, E, G, Q, Ar, n, m, and p are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

4'-AMINO CYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): formula (I) wherein Cy is selected from formula (Il) and wherein R1, R2, R3, Q, G, Ar, m, n and p are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

3' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): wherein Q, R1, R4, m and Ar are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.

Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.